Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

Mise à jour : Il y a 4 ans
Référence : NCT01305655

Femme et Homme

Extrait

Early intervention in children and adolescents who experience delayed MTX-clearance and renal dysfunction in ALL treatments with the enzyme Glucarpidase which rapidly hydrolyses MTX to non-toxic metabolites to avoid life threatening complications.


Critère d'inclusion

  • Acute lymphoblastic leukemia [ALL]


Liens